Allena 177-302 Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients with Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study

Administered By

Awarded By

Contributors

Start/End

  • January 15, 2021 - February 28, 2026